Forum Discussions
These novel Fora, in WEF-style format, will bring together corporate participants, neuroscientists and clinicians with outstanding experience in “hottest” research topics in the field of neurodegeneration to discuss the impact of newest preclinical results and cutting edge clinical findings on understanding and treatment development of neurodegenerative disorders. The objective is to exchange novel insights, challenges and solutions on the joint path forward to defining the future of Alzheimer’s and Parkinson’s therapeutics.
Each forum will be a moderated discussion with maximum 3 minutes introduction statement from each participant followed by questions from the audience submitted via the Chat function in the virtual platform and introduced to the discussion by the moderator. The forum is also open for journalists from different media, including lay press in and may report on progress made by the leaders in this field.
The forum discussions will be streamed live and participants can send in questions for live Q&A with the speakers.
All live sessions will be broadcast according to the scheduled Central European Time (CET) times listed below.
FORUM TITLE
Co-Moderators
Discussants*
Dates and Times
FORUM ON IMPACT OF COVID-19 ON NEURODEGENERATIVE DISEASES
Roger Nitsch (Switzerland)
Ronald Petersen (USA)
J. Attems (United Kingdom)
T. Babic (Austria)
J. Galvin (USA)
M. Heneka (Germany)
D. Thal (Belgium)
T. Wyss-Coray (USA)
March 10, 2021
18:00 – 19:00 CET
FORUM ON APPLICATIONS OF NEUROPSYCHOLOGY, PET, MRI, EEG, PLASMA AND CSF FOR DIAGNOSIS AND ASSESSMENT OF TREATMENT EFFECTS
Henrik Zetterberg (Sweden)
Melissa Murray (USA)
J. Beaver (USA)
K. Gerwert (Germany)
O. Hansson (Sweden)
C. Jack (USA)
A. Nordberg (Sweden)
M. Weiner (USA)
March 10, 2021
19:30 – 20:30
FORUM ON PHASE I-II CLINICAL TRIALS IN ALZHEIMER’S DISEASE
Jeffrey Cummings (USA)
Manfred Windisch (Austria)
T. A. Gallego (Spain)
E. Giacobini (Switzerland)
C. Fisher (USA)
G. Kerchner (Switzerland)
A. Korczyn (Israel)
J. Landen (USA)
March 11, 2021
18:30 – 19:30
FORUM ON TRANSLATIONAL DRUG DISCOVERY IN PD/ LBD PHASE I-III – RECENT UPDATES
Jamie Eberling (USA)
Walter Koroshetz (USA)
J. Growdon (USA)
P. Mclean (USA)
W. Poewe (Austria)
A. Schapira (UK)
F. Stocchi (Italy)
G. Kinney (USA)
March 12, 2021
18:30 – 19:30
FORUM ON PHASE III CLINICAL TRIALS IN ALZHEIMER’S DISEASE
Selina Koch (USA)
John Morris (USA)
R. Bateman (USA)
S. B. Haeberlein (USA)
M. Irizarry (USA)
G. Rabinovici (USA)
P. Scheltens (Netherlands)
March 13, 2021
18:30 – 19:30
